Cargando…

Diabetic ketoacidosis (DKA) in type 1 diabetes mellitus (T1DM) temporally related to COVID-19 vaccination

SARS-CoV-2 pandemic has claimed millions of lives since its first identification in December 2019. Patients with diabetes are at a high risk of adverse outcomes after COVID-19 infection, whereas infection itself can be associated with severe hyperglycemia, including hyperglycemic emergencies. While...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ganakumar, Vanishri, Jethwani, Parth, Roy, Ayan, Shukla, Ravindra, Mittal, Madhukar, Garg, Mahendra Kumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Diabetes India. Published by Elsevier Ltd. 2022
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687715/ https://www.ncbi.nlm.nih.gov/pubmed/34954484 http://dx.doi.org/10.1016/j.dsx.2021.102371

Ejemplares similares

Effect of COVID-19 on the clinical course of diabetic ketoacidosis (DKA) in people with type 1 and type 2 diabetes
por: Kempegowda, Punith, et al.
Publicado: (2021)

Latent Autoimmune Diabetes in an Adult Male Presenting With Diabetic Ketoacidosis (DKA)
por: Imam, Syed K, et al.
Publicado: (2023)

Incidence and prevalence of diabetic ketoacidosis (DKA) among adults with type 1 diabetes mellitus (T1D): a systematic literature review
por: Farsani, Soulmaz Fazeli, et al.
Publicado: (2017)

Correction: Incidence and prevalence of diabetic ketoacidosis (DKA) among adults with type 1 diabetes mellitus (T1D): a systematic literature review
Publicado: (2017)

The DKA that wasn't: a case of euglycemic diabetic ketoacidosis due to empagliflozin
por: Candelario, Nellowe, et al.
Publicado: (2016)

Noninvasive monitoring capnometry for continuous monitoring of metabolic status in pediatric diabetic ketoacidosis (DKA)
por: Abramo, TJ, et al.
Publicado: (2001)

FRI642 The Effect Of Early Basal Insulin Administration On Diabetic Ketoacidosis (DKA) Management
por: Al-Marsumi, Hadeel, et al.
Publicado: (2023)

THU374 Fulminant Type 1 Diabetes Mellitus And DKA Secondary To Pembrolizumab
por: Iqbal, Iqra, et al.
Publicado: (2023)

Highly Sensitive Electrochemical Sensor for Diagnosis of Diabetic Ketoacidosis (DKA) by Measuring Ketone Bodies in Urine
por: Go, Anna, et al.
Publicado: (2021)

Severe Acute Kidney Injury Secondary to Rhabdomyolysis in Diabetic Ketoacidosis (DKA): A Case Report
por: AL Aldahan, Zahidah A, et al.
Publicado: (2022)

A clinical and biochemical comparative study of diabetic ketoacidosis (DKA) in newly diagnosed vs known cases of Type 1 diabetic children
por: Albuali, Waleed H., et al.
Publicado: (2023)

Diabetic Ketoacidosis Secondary to New Onset Type 1 Diabetes Mellitus Related to Pembrolizumab Therapy
por: Hernandez, Andrea, et al.
Publicado: (2021)

THU380 A Case Of Alpelisib Induced Diabetic Ketoacidosis (Dka) In A Patient With Type 2 Diabetes Mellitus And Rechallenge With SGLT2 Inhibitor
por: Sekar, Vijaykumar, et al.
Publicado: (2023)

PSUN267 New-Onset Type 1 Diabetes (T1D) In a Child Presenting With Diabetic Ketoacidosis (DKA) and Severe Hypertriglyceridemia Without Pancreatitis
por: Vitale, Rebecca, et al.
Publicado: (2022)

Diabetic ketoacidosis at the onset of Type 1 diabetes in young children: Is it time to launch a tailored campaign for DKA prevention in children <5 years?
por: Iovane, Brunella, et al.
Publicado: (2018)

Comparing the Efficacy of a Nurse-Driven and a Physician-Driven Diabetic Ketoacidosis (DKA) Treatment Protocol
por: Anis, Takla R, et al.
Publicado: (2021)

Non-medicalization of medical science: Rationalization for future
por: Mittal, Madhukar, et al.
Publicado: (2022)

Tubelight Adrenals in Diabetic Ketoacidosis
por: Yadav, Prakrati, et al.
Publicado: (2020)

Duloxetine-induced hypertensive urgency in type 2 diabetes mellitus with diabetic neuropathy
por: Shukla, Ravindra, et al.
Publicado: (2020)

Risks associated with acute pancreatitis (AP) with diabetic ketoacidosis (DKA) in COVID-19 patients: a literature review
por: Devi, Sundru Manjulata, et al.
Publicado: (2023)

A Case of Euglycemic Diabetic Ketoacidosis (DKA), Influenza, and a Dipeptidyl Peptidase-4 (DPP-4) Inhibitor
por: Jeong, Su Hyun, et al.
Publicado: (2023)

Case report and literature review: T2DM with DKA, HHS and rhabdomyolysis
por: Li, Wenjing, et al.
Publicado: (2013)

Combined diabetic ketoacidosis and hyperosmolar hyperglycemic state in type 1 diabetes mellitus induced by immune checkpoint inhibitors: Underrecognized and underreported emergency in ICIs-DM
por: Zhang, Wenjing, et al.
Publicado: (2023)

SUN-178 A Not So "Sweet" DKA: A Case of Euglycemic Diabetic Ketoacidosis Caused by Dapagliflozin/Liraglutide Combination
por: Sideri Gugger, Aristea, et al.
Publicado: (2019)

ODP628 Quality Improvement Project (QIP) On Management Of Diabetic Ketoacidosis (DKA) In Adults In A District General Hospital.
por: Haddad, Aiman, et al.
Publicado: (2022)

Treatment of Diabetic Ketoacidosis (DKA)/Hyperglycemic Hyperosmolar State (HHS): Novel Advances in the Management of Hyperglycemic Crises (UK Versus USA)
por: Dhatariya, Ketan K., et al.
Publicado: (2017)

MON-154 Abnormal Glucose Homeostasis in Spinal Muscular Atrophy (SMA) Leading to a Transient Episode of Diabetic Ketoacidosis (DKA)
por: Hossain, Sabina, et al.
Publicado: (2019)

MON-083 Childhood Diabetic Ketoacidosis (DKA) in New-Onset and Established Patients in Central Illinois: Contributing Factors and Risk Stratification
por: Szymczuk, Vivian, et al.
Publicado: (2020)

Diabetic Ketoacidosis Complicating Gestational Diabetes Mellitus
por: Villavicencio, Camila Alejandra, et al.
Publicado: (2022)

MON-133 Exacerbation of Lactic Acidosis During DKA in Adolescents with Type 1 Diabetes Mellitus with Mauriac Syndrome
por: Sodhi, Misha, et al.
Publicado: (2019)

SAT-LB112 An Unusual Case of Ipilimumab/Nivolumab Induced Fulminant Diabetic Ketoacidosis (DKA) in a Non Diabetic Patient - a Case Report
por: Abdelmasih, Randa, et al.
Publicado: (2020)

Clinical and biochemical profile of 786 sequential episodes of diabetic ketoacidosis in adults with type 1 and type 2 diabetes mellitus
por: Ooi, Emma, et al.
Publicado: (2021)

Neutrophil-to-Lymphocyte Ratio Adds Valuable Information Regarding the Presence of DKA in Children with New-Onset T1DM
por: Scutca, Alexandra-Cristina, et al.
Publicado: (2022)

QTc and QTd in Children with Type 1 Diabetes Mellitus during Diabetic Ketoacidosis
por: Youssef, Omneya I., et al.
Publicado: (2012)

Pediatrician level of knowledge on management of type 1 diabetes mellitus and diabetic ketoacidosis
por: Artati, Ratna Dewi, et al.
Publicado: (2013)

The diet in children with diabetes mellitus (DM)
por: Iafusco, Dario, et al.
Publicado: (2014)

Molecular biomarkers in diabetes mellitus (DM)
por: Aghaei Zarch, Seyed Mohsen, et al.
Publicado: (2020)

SAT-676 Pembrolizumab Induced Worsening Glycemic Control and DKA in Type 2 Diabetes Mellitus
por: Goud, Sarita, et al.
Publicado: (2020)

Macrophages in diabetes mellitus (DM) and COVID-19: do they trigger DM?
por: Kloc, Małgorzata, et al.
Publicado: (2020)

Clinical and biochemical characteristics of familial type 1 diabetes mellitus (FT1DM) compared to non-familial type 1 DM (NFT1DM)
por: Alyafei, Fawzia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vfv81m3bjmatggqit99shbppdt